Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivasnephrology-urology-fluids-and-electrolytes

Paeds Vivas · nephrology-urology-fluids-and-electrolytes

Oedema and nephrotic syndrome — branching viva

Branching viva from the puffy toddler at first presentation, through the KDIGO 2021 definition and the initial prednisolone regimen, the four-week response classification that separates steroid-sensitive from steroid-resistant disease, the move to steroid-sparing therapy in the frequently-relapsing child, to the unwell nephrotic child with abdominal pain who demands recognition of peritonitis and hypovolaemia.

branching clinical structured oral
On this page & tools

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP General PaediatricsRACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
You are the paediatric registrar on the ward and in the emergency department. The examiner asks you to assess three children: a three-year-old with new periorbital and ankle oedema and heavy proteinuria; a seven-year-old who has not cleared the proteinuria after four weeks of daily prednisolone; and a five-year-old with frequently-relapsing disease who arrives with abdominal pain and fever. The examiner releases information in stages.

Stem 1 — Three-year-old with new oedema and heavy proteinuria (5 minutes)

A three-year-old boy has four days of morning periorbital puffiness and ankle swelling. A first morning urine protein-to-creatinine ratio is 290 mg/mmol, his serum albumin is 20 g/L, his blood pressure is normal, his complement is normal, and there is no haematuria. [1]

Branch A (examiner): State the KDIGO 2021 diagnostic criteria, and explain why the first morning sample is essential rather than a random daytime dipstick. (2 marks) [1] [10]

Branch B (examiner): Outline the initial prednisolone regimen in full, including the daily dose, the maximum, the conversion to alternate-day dosing, and the total course duration. Why is the course kept within twelve weeks? (2 marks) [1] [3]

Branch C (examiner): What will you teach the family to do at home, and what are the three danger signs that should prompt them to seek urgent review? (1 mark) [11]

Stem 2 — Seven-year-old not cleared after four weeks of steroids (5 minutes)

A seven-year-old boy started daily prednisolone 60 mg/m2/day four weeks ago for a first episode of nephrotic syndrome. His home dipsticks have shown persistent 3+ protein throughout, and he remains oedematous. His blood pressure is at the 95th percentile and his complement is normal. [5]

Branch A (examiner): What is the correct diagnostic label at this point, and how does it change the management pathway compared with the steroid-sensitive child? (2 marks) [1] [5]

Branch B (examiner): Outline the investigations you would now request, including the role of renal biopsy and genetic testing, and the first-line pharmacological agent class you would introduce. (2 marks) [5] [6]

Branch C (examiner): What is the prognostic significance of steroid resistance for this child's long-term kidney function, and how does the finding of a pathogenic genetic variant alter the counselling about treatment and transplant? (1 mark) [5] [6]

Stem 3 — Five-year-old with frequently-relapsing disease, abdominal pain and fever (5 minutes)

A five-year-old girl with frequently-relapsing steroid-sensitive nephrotic syndrome (four relapses in the last year) presents with a new relapse, now complicated by abdominal pain, fever of 38.8 degrees Celsius and tachycardia. Her capillary refill is 4 seconds and her serum albumin is 14 g/L. [11]

Branch A (examiner): What complication must you assume is present, what is the immediate investigation and empirical treatment, and why is she vulnerable to it? (2 marks) [11]

Branch B (examiner): She is also intravascularly depleted despite her oedema. State the resuscitation fluid, the dose and the accompanying drug, and explain why diuretics alone would be dangerous. (2 marks) [7]

Branch C (examiner): Once she is stabilised, what steroid-sparing options are now indicated for her frequently-relapsing course, and what is the evidence-based role of rituximab? (1 mark) [1] [4]

References

  1. [1]Rovin BH; Adler SG; Barratt J; et al Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. Kidney Int, 2021.PMID 34556300
  2. [2]Rovin BH; Caster DJ; Cattran DC; et al Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int, 2019.PMID 30665569
  3. [3]Teeninga N; Kist-van Holthe JE; van Rijswijk N; et al Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol, 2013.PMID 23274956
  4. [4]Iijima K; Sako M; Nozu K; et al Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet, 2014.PMID 24965823
  5. [5]Trautmann A; Vivarelli M; Samuel S; et al IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome. Pediatr Nephrol, 2020.PMID 32382828
  6. [6]Tullus K; Webb H; Bagga A; et al Management of steroid-resistant nephrotic syndrome in children and adolescents. Lancet Child Adolesc Health, 2018.PMID 30342869
  7. [7]Rheault MN; Zhang L; Selewski DT; et al AKI in Children Hospitalized with Nephrotic Syndrome. Clin J Am Soc Nephrol, 2015.PMID 26450933
  8. [8]Kerlin BA; Haworth K; Smoyer WE; et al Venous thromboembolism in pediatric nephrotic syndrome. Pediatr Nephrol, 2014.PMID 23812352
  9. [9]Boyer O; Schaefer F; Haffner D; et al Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group. Nat Rev Nephrol, 2021.PMID 33514942
  10. [10]Bagga A; Mantan M Nephrotic syndrome in children. Indian J Med Res, 2005.PMID 16106086
  11. [11]Gipson DS; Massengill SF; Yao L; et al Management of childhood onset nephrotic syndrome. Pediatrics, 2009.PMID 19651590
  12. [12]Zhu H; Qi J; Schoepf J; et al Prevalence and Associated Risk Factors of Pulmonary Embolism in Children and Young Adults With Nephrotic Syndrome: A Chinese Large Cohort Study. J Thorac Imaging, 2021.PMID 34269751